Alpharma is a well-established global pharmaceutical company that focuses on the development, manufacturing, and marketing of generic and specialty pharmaceutical products. Founded in 1948, the company has built a strong reputation for its commitment to providing high-quality, cost-effective medications. Headquartered in Bridgewater, New Jersey, Alpharma operates in various therapeutic areas, including analgesics, cardiovascular, endocrinology, gastroenterology, and respiratory health. The company’s extensive portfolio encompasses a wide range of pharmaceutical products, including solid oral dosage forms, sterile injectables, and topical medications. Alpharma operates production facilities across the United States, ensuring efficient manufacturing processes and adherence to strict quality standards. The company consistently invests in research and development activities to introduce innovative generic products, contributing to affordable healthcare solutions for patients globally. Recognizing the importance of regulatory compliance, Alpharma maintains a robust quality assurance system to ensure the safety and efficacy of its pharmaceutical products. These products adhere to rigorous regulatory standards set forth by various authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Alpharma also collaborates with other pharmaceutical companies and healthcare professionals to enhance its research capabilities and expand its product offerings. This collaborative approach helps the company address the diverse needs of patients worldwide while prioritizing their health and well-being. With its commitment to excellence in pharmaceutical manufacturing and a steadfast focus on meeting patient needs, Alpharma continues to be a key player in the global pharmaceutical industry.